Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.
Age ≥ at 18 years old,
Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy,
thyroid cancer,
a neuroendocrine tumor or any SSTR positive tumours (like meningiomas) receiving PRRT
Patient not affiliated to a social security scheme,
Subject under tutelage, curatorship or safeguard of justice,
Patient in an emergency situation
Patient whose regular monitoring is a priori impossible for psychological, family, social or geographical reasons,
Single group
Biological collection
Other interventionThe biological collection will also include samples of blood samples collected before and during treatment.
tumor collection
Other interventionTumor collection (diagnosis) will be done for thyroid cancer and neuroencrine
Proportion of patients who gave their consent to participate in the study
The proportion of patients who consent to participate in the study among the screened patients
Click on the lead sponsor to view all of their trials.
